A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

One of the expectations related to AI tech is that advanced artificial intelligence may improve human life in profound ways once it's able to assist with breakthrough discoveries or come up with ...

A laboratory preclinical model of the most common special histological subtype of breast cancer. Courtesy of George Sflomos ...

Neoadjuvant pembrolizumab (3 doses) in stage I–III disease yielded a 71% pCR rate and only one melanoma-specific survival event at 3 years post-resection. Experts discuss the SWOG S1512 trial of ...

One way cancer specialists detect the disease is by examining cells and bodily fluids under a microscope, a time-consuming ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...